Methods in Molecular Biology TMTM
Volume 226 PCRPCR ProtocolsProtocols SSECONDECOND EEDITIONDITION
EditedEdited byby JohnJohn M.M. S.S. BartlettBartlett DavidDavid StirlingStirling PCR Protocols Second Edition M E T H O D S I N M O L E C U L A R B I O L O G Y TM
John M. Walker, SERIES EDITOR
251. HPLC of Peptides and Proteins: Methods and Protocols, edited by 217. Neurogenetics: Methods and Protocols, edited by Nicholas T. Marie-Isabel Aguilar, 2004 Potter, 2003 250. MAP Kinase Signaling Protocols, edited by Rony Seger, 2004 216. PCR Detection of Microbial Pathogens: Methods and Protocols, 249. Cytokine Protocols, edited by Marc De Ley, 2004 edited by Konrad Sachse and Joachim Frey, 2003 248. Antibody Engineering: Methods and Protocols, edited by Benny K. 215. Cytokines and Colony Stimulating Factors: Methods and Proto- C. Lo, 2004 cols, edited by Dieter Körholz and Wieland Kiess, 2003 247. Drosophila Cytogenetics Protocols, edited by Daryl S. Henderson, 214. Superantigen Protocols, edited by Teresa Krakauer, 2003 2004 213. Capillary Electrophoresis of Carbohydrates, edited by Pierre 246. Gene Delivery to Mammalian Cells: Volume 2: Viral Gene Transfer Thibault and Susumu Honda, 2003 Techniques, edited by William C. Heiser, 2004 212. Single Nucleotide Polymorphisms: Methods and Protocols, edited 245. Gene Delivery to Mammalian Cells: Volume 1: Nonviral Gene Trans- by Piu-Yan Kwok, 2003 fer Techniques, edited by William C. Heiser, 2004 211. Protein Sequencing Protocols, Second Edition, edited by Bryan John 244. Protein Purification Protocols, Second Edition, edited by Paul Cut- Smith, 2003 ler, 2004 210. MHC Protocols, edited by Stephen H. Powis and Robert W. Vaughan, 243. Chiral Separations: Methods and Protocols, edited by Gerald Gübitz 2003 and Martin G. Schmid, 2004 209. Transgenic Mouse Methods and Protocols, edited by Marten Hofker 242. Atomic Force Microscopy: Methods and Applications, edited by Pier and Jan van Deursen, 2002 Carlo Braga and Davide Ricci, 2004 208. Peptide Nucleic Acids: Methods and Protocols, edited by Peter E. 241. Cell Cycle Checkpoint Control Protocols, edited by Howard B. Nielsen, 2002 Lieberman, 2004 207. Recombinant Antibodies for Cancer Therapy: Methods and Proto- 240. Mammalian Artificial Chromosomes: Methods and Protocols, ed- cols. edited by Martin Welschof and Jürgen Krauss, 2002 ited by Vittorio Sgaramella and Sandro Eridani, 2003 206. Endothelin Protocols, edited by Janet J. Maguire and Anthony P. 239. Cell Migration in Inflammation and Immunity: Methods and Pro- Davenport, 2002 tocols, edited by Daniele D’Ambrosio and Francesco Sinigaglia, 2003 205. E. coli Gene Expression Protocols, edited by Peter E. Vaillancourt, 238. Biopolymer Methods in Tissue Engineering, edited by Anthony P. 2002 Hollander and Paul V. Hatton, 2003 204. Molecular Cytogenetics: Protocols and Applications, edited by Yao- 237. G Protein Signaling: Methods and Protocols, edited by Alan V. Smrcka, Shan Fan, 2002 2003 203. In Situ Detection of DNA Damage: Methods and Protocols, edited 236. Plant Functional Genomics: Methods and Protocols, edited by Erich by Vladimir V. Didenko, 2002 Grotewold, 2003 202. Thyroid Hormone Receptors: Methods and Protocols, edited by Aria 235. E. coli Plasmid Vectors: Methods and Applications, edited by Nicola Baniahmad, 2002 Casali and Andrew Preston, 2003 201. Combinatorial Library Methods and Protocols, edited by Lisa B. 234. p53 Protocols, edited by Sumitra Deb and Swati Palit Deb, 2003 English, 2002 233. Protein Kinase C Protocols, edited by Alexandra C. Newton, 2003 200. DNA Methylation Protocols, edited by Ken I. Mills and Bernie H. 232. Protein Misfolding and Disease: Principles and Protocols, edited Ramsahoye, 2002 by Peter Bross and Niels Gregersen, 2003 199. Liposome Methods and Protocols, edited by Subhash C. Basu and 231. Directed Evolution Library Creation: Methods and Manju Basu, 2002 Protocols, edited by Frances H. Arnold and George Georgiou, 2003 198. Neural Stem Cells: Methods and Protocols, edited by Tanja Zigova, 230. Directed Enzyme Evolution: Screening and Selection Juan R. Sanchez-Ramos, and Paul R. Sanberg, 2002 Methods, edited by Frances H. Arnold and George Georgiou, 2003 197. Mitochondrial DNA: Methods and Protocols, edited by William C. 229. Lentivirus Gene Engineering Protocols, edited by Maurizio Copeland, 2002 Federico, 2003 196. Oxidants and Antioxidants: Ultrastructure and Molecular Biology 228. Membrane Protein Protocols: Expression, Purification, and Char- Protocols, edited by Donald Armstrong, 2002 acterization, edited by Barry S. Selinsky, 2003 195. Quantitative Trait Loci: Methods and Protocols, edited by Nicola 227. Membrane Transporters: Methods and Protocols, edited by Qing J. Camp and Angela Cox, 2002 Yan, 2003 194. Posttranslational Modifications of Proteins: Tools for Functional 226. PCR Protocols, Second Edition, edited by John M. S. Bartlett and Proteomics, edited by Christoph Kannicht, 2002 David Stirling, 2003 193. RT-PCR Protocols, edited by Joe O’Connell, 2002 225. Inflammation Protocols, edited by Paul G. Winyard and Derek A. 192. PCR Cloning Protocols, Second Edition, edited by Bing-Yuan Chen Willoughby, 2003 and Harry W. Janes, 2002 224. Functional Genomics: Methods and Protocols, edited by Michael 191. Telomeres and Telomerase: Methods and Protocols, edited by John J. Brownstein and Arkady Khodursky, 2003 A. Double and Michael J. Thompson, 2002 223. Tumor Suppressor Genes: Volume 2: Regulation, Function, and 190. High Throughput Screening: Methods and Protocols, edited by Medicinal Applications, edited by Wafik S. El-Deiry, 2003 William P. Janzen, 2002 222. Tumor Suppressor Genes: Volume 1: Pathways and Isolation Strat- 189. GTPase Protocols: The RAS Superfamily, edited by Edward J. egies, edited by Wafik S. El-Deiry, 2003 Manser and Thomas Leung, 2002 221. Generation of cDNA Libraries: Methods and Protocols, edited by 188. Epithelial Cell Culture Protocols, edited by Clare Wise, 2002 Shao-Yao Ying, 2003 187. PCR Mutation Detection Protocols, edited by Bimal D. M. 220. Cancer Cytogenetics: Methods and Protocols, edited by John Theophilus and Ralph Rapley, 2002 Swansbury, 2003 186. Oxidative Stress Biomarkers and Antioxidant Protocols, edited 219. Cardiac Cell and Gene Transfer: Principles, Protocols, and Appli- by Donald Armstrong, 2002 cations, edited by Joseph M. Metzger, 2003 185. Embryonic Stem Cells: Methods and Protocols, edited by Kursad 218. Cancer Cell Signaling: Methods and Protocols, edited by David Turksen, 2002 M. Terrian, 2003 184. Biostatistical Methods, edited by Stephen W. Looney, 2002 M E T H O D S I N M O L E C U L A R B I O L O G Y ™
PCR Protocols Second Edition
Edited by John M. S. Bartlett Department of Surgery, Glasgow Royal Infirmary, Glasgow, UK and David Stirling Department of Hematology, Royal Infirmary of Edinburgh, Edinburgh, UK
Humana Press Totowa, New Jersey © 2003 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 www.humanapress.com
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. Methods in Molecular Biology™ is a trademark of The Humana Press Inc.
The content and opinions expressed in this book are the sole work of the authors and editors, who have warranted due diligence in the creation and issuance of their work. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences arising from the information or opinions presented in this book and make no warranty, express or implied, with respect to its contents.
This publication is printed on acid-free paper. ∞ ANSI Z39.48-1984 (American Standards Institute) Permanence of Paper for Printed Library Materials.
Production Editor: Robin B. Weisberg.
Cover illustration: Images showing colored bands from fluorescent genotyping. Artwork courtesy of David Stirling. Cover design by Patricia F. Cleary.
For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel.: 973-256-1699; Fax: 973-256-8341; E-mail: [email protected]; or visit our Website: www.humanapress.com
Photocopy Authorization Policy: Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $25.00 per copy, is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is [0-89603-642-1/03 $25.00].
Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1
Library of Congress Cataloging in Publication Data
PCR protocols / edited by John M.S. Bartlett, David Stirling. --2nd ed. p. cm. -- (Methods in molecular biology ; v. 226) Includes bibliographical references and index. ISBN 0-89603-642-1 (hardcover) (alk. paper); ISBN 0-89603-627-8 (combbound); 1-59259-384-4 (e-ISBN) ISSN 1064-3745 1. Polymerase chain reaction—Laboratory manuals. I. Bartlett, John M. S. II. Stirling, David. III. Series. QP606.D46P3595 2003 572'.43--dc21 2003042324 Preface
Since the discovery/invention of the polymerase chain reaction (PCR) in the mid-1980s, use of this technology has become so widespread that few researchers will progress far in their careers without exposure to PCR in one form or another. The robustness and exquisite sensitivity of PCR has led to the development of a multitude of protocols that exploit different aspects of this methodology. PCR has thus been used to analyze nucleic acids from all known phyla, and even some species extinct for hundreds of years. Disciplines as diverse as ecology, forensic medicine, food produc- tion, and archaeology employ PCR analyses as key components of population moni- toring, genetic fingerprinting, quality assurance, and research. The place of PCR as a cornerstone of current and future scientific endeavor is beyond question. Such has been the expansion in PCR methodologies that a revision of the previous edition of PCR Protocols dealing with PCR was considered essential. In undertaking this revision we were conscious that although much has changed, the fundamentals of PCR remain unaltered. Indeed in some areas, methods developed 5 or even 10 years ago remain as effective and useful as more recent developments. How- ever, in other areas rapid progress has led to exciting new advances. We are also conscious of a “PCR generation gap,” whereby many of the early developments in PCR have passed into folklore. The usefulness of this second edition of PCR Protocols to all researchers will, we trust, be enhanced by the provision of an introductory section dealing both with the history of PCR and the legal and practical issues surrounding the development of PCR-based methods today. Such is the diversity of the PCR methodologies currently available that it would be impossible to provide an exhaustive PCR manual that covers all aspects of the technology. Many of the sections we have included can be, and in some cases have been, expanded into separate publications. Therefore in producing PCR Protocols we have sought to select those techniques that form a core manual for both the PCR novice and the adept. The methods we have selected represent worked examples from many fields that can be reproduced and adapted for use within the reader’s laboratory. We have sought to provide both a primer to allow the reader to gain basic experience of different PCR techniques, and in-depth insight into a variety of the more complex applications of PCR. Each section has been introduced by an overview chapter whose aim is to provide researchers with an understanding of the applications and limitations of the techniques that follow. As with each volume in the Methods in Molecular Biology series, clear instructions for the performance of the various protocols is supplemented by additional technical notes that provide valuable insights into the working of the technique in question. Though often brief, these notes provide essential details that allow for a successful outcome.
v vi Preface
We would like to express our gratitude to each of the contributors to PCR Protocols, 2nd edition, who have been patient over the period required to collate their contributions. Finally, thanks are owed to our wives, Dorothy and Muriel, for their patience during the long hours we have spent on this volume. John M. S. Bartlett David Stirling Contents
Preface ...... v Contributors ...... xiii
PART I. INTRODUCTION TO PCR 1 A Short History of the Polymerase Chain Reaction John M. S. Bartlett and David Stirling ...... 3 2 PCR Patent Issues Peter Carroll and David Casimir ...... 7 3 Equipping and Establishing a PCR Laboratory Susan McDonagh ...... 15 4 Quality Control in PCR David Stirling ...... 21
PART II. PREPARATION OF NUCLEIC ACID TEMPLATES 5 Extraction of Nucleic Acid Templates John M. S. Bartlett...... 27 6 Extraction of DNA from Whole Blood John M. S. Bartlett and Anne White...... 29 7 DNA Extraction from Tissue Helen Pearson and David Stirling...... 33 8 Extraction of DNA from Microdissected Archival Tissues James J. Going...... 35 9 RNA Extraction from Blood Helen Pearson ...... 43 10 RNA Extraction from Frozen Tissue John M. S. Bartlett...... 45 11 RNA Extraction from Tissue Sections Helen Pearson ...... 47 12 Dual DNA/RNA Extraction David Stirling and John M. S. Bartlett ...... 49 13 DNA Extraction from Fungi, Yeast, and Bacteria David Stirling ...... 53 vii viii Contents
14 Isolation of RNA Viruses from Biological Materials Susan McDonagh ...... 55 15 Extraction of Ancient DNA Wera M. Schmerer ...... 57 16 DNA Extraction from Plasma and Serum David Stirling ...... 63 17 Technical Notes for the Detection of Nucleic Acids John M. S. Bartlett...... 65 18 Technical Notes for the Recovery and Purification of PCR Products from Acrylamide Gels David Stirling ...... 77
PART III. BASIC PCR METHODS 19 PCR Primer Design David L. Hyndman and Masato Mitsuhashi ...... 81 20 Optimization of Polymerase Chain Reactions Haiying Grunenwald ...... 89 21 Subcycling PCR for Long-Distance Amplifications of Regions with High and Low Guanine–Cystine Content: Amplification of the Intron 22 Inversion of the FVIII Gene David Stirling ...... 101 22 Rapid Amplification of cDNA Ends Xin Wang and W. Scott Young III...... 105 23 Randomly Amplified Polymorphic DNA Fingerprinting: The Basics Ranil S. Dassanayake and Lakshman P. Samaranayake ...... 117 24 Microsphere-Based Single Nucleotide Polymorphism Genotyping Marie A. Iannone, J. David Taylor, Jingwen Chen, May-Sung Li, Fei Ye, and Michael P. Weiner ...... 123 25 Ligase Chain Reaction William H. Benjamin, Jr., Kim R. Smith, and Ken B. Waites ...... 135 26 Nested RT-PCR in a Single Closed Tube Antonio Olmos, Olga Esteban, Edson Bertolini, and Mariano Cambra ...... 151 27 Direct PCR from Serum: Application to Viral Genome Detection Kenji Abe ...... 161 Contents ix
28 Long PCR Amplification of Large Fragments of Viral Genomes: A Technical Overview Raymond Tellier, Jens Bukh, Suzanne U. Emerson, and Robert H. Purcell...... 167 29 Long PCR Methodology Raymond Tellier, Jens Bukh, Suzanne U. Emerson, and Robert H. Purcell...... 173
PART IV. ULTRASENSITIVE AND QUANTITATIVE PCR 30 Qualitative and Quantitative PCR: A Technical Overview David Stirling ...... 181 31 Ultrasensitive PCR Detection of Tumor Cells in Myeloma Friedrich W. Cremer and Marion Moos ...... 185 32 Ultrasensitive Quantitative PCR to Detect RNA Viruses Susan McDonagh ...... 197 33 Quantitative PCR for cAMP RI Alpha mRNA: Use of Site-Directed Mutation and PCR Mimics John M. S. Bartlett...... 205 34 Quantitation of Multiple RNA Species Ron Kerr...... 211
PART V. TRANSCRIPTOME ANALYSIS 35 Differential Display: A Technical Overview John M. S. Bartlett...... 217 36 AU-Differential Display, Reproducibility of a Differential mRNA Display Targeted to AU Motifs Orlando Dominguez, Lidia Sabater, Yaqoub Ashhab, Eva Belloso, and Ricardo Pujol-Borrell ...... 225 37 PCR Fluorescence Differential Display Kostya Khalturin, Sergej Kuznetsov, and Thomas C. G. Bosch ...... 237 38 Microarray Analysis Using RNA Arbitrarily Primed PCR Steven Ringquist, Gaelle Rondeau, Rosa-Ana Risques, Takuya Higashiyama, Yi-Peng Wang, Steffen Porwollik, David Boyle, Michael McClelland, and John Welsh ...... 245 39 Oligonucleotide Arrays for Genotyping: Enzymatic Methods for Typing Single Nucleotide Polymorphisms and Short Tandem Repeats Stephen Case-Green, Clare Pritchard, and Edwin Southern ...... 255 x Contents
40 Serial Analysis of Gene Expression Karin A. Oien ...... 271
PART VI. MUTATIONS AND POLYMORPHISMS 41 Mutation and Polymorphism Detection: A Technical Overview Joanne Edwards and John M. S. Bartlett ...... 287 42 Combining Multiplex and Touchdown PCR for Microsatellite Analysis Kanokporn Rithidech and John J. Dunn ...... 295 43 Detection of Microsatellite Instability and Loss of Heterozygosity Using DNA Extracted from Formalin-Fixed Paraffin-Embedded Tumor Material by Fluorescence-Based Multiplex Microsatellite PCR Joanne Edwards and John M. S. Bartlett ...... 301 44 Reaction of Shadow Band Synthesis During PCR Amplification of Repetitive Sequences from Modern and Ancient DNA Wera M. Schmerer ...... 309 45 Degenerate Oligonucleotide-Primed PCR Michaela Aubele and Jan Smida...... 315 46 Mutation Detection Using RT-PCR-RFLP Hitoshi Nakashima, Mitsuteru Akahoshi, and Yosuke Tanaka ...... 319 47 Multiplex Amplification Refractory Mutation System for the Detection of Prothrombotic Polymorphisms David Stirling ...... 323 48 PCR-SSCP Analysis of Polymorphism: A Simple and Sensitive Method for Detecting Differences Between Short Segments of DNA Mei Han and Mary Ann Robinson ...... 327
PART VII. PCR-BASED SEQUENCING 49 Sequencing: A Technical Overview David Stirling ...... 337 50 Preparation and Direct Automated Cycle Sequencing of PCR Products Susan E. Daniels ...... 341 51 Nonradioactive PCR Sequencing Using Digoxigenin Siegfried Kösel, Christoph B. Lücking, Rupert Egensperger, and Manuel B. Graeber ...... 347 Contents xi
52 Direct Sequencing by Thermal Asymmetric PCR Georges-Raoul Mazars and Charles Theillet ...... 355 53 Analysis of Nucleotide Sequence Variations by Solid-Phase Minisequencing Anu Suomalainen and Ann-Christine Syvänen...... 361 54 Direct Sequencing with Highly Degenerate and Inosine-Containing Primers Zhiyuan Shen, Jingmei Liu, Robert L. Wells, and Mortimer M. Elkind ...... 367 55 Determination of Unknown Genomic Sequences Without Cloning Jean-Pierre Quivy and Peter B. Becker ...... 373 56 Cloning PCR Products for Sequencing in M13 Vectors David Walsh ...... 385 57 DNA Rescue by the Vectorette Method Marcia A. McAleer, Alison J. Coffey, and Ian Dunham ...... 393 58 Technical Notes for Sequencing Difficult Templates David Stirling ...... 401
PART VIII. IN SITU PCR AND PRINS 59 PCR-Based Detection of Nucleic Acids in Chromosomes, Cells, and Tissues: Technical Considerations on PRINS and In Situ PCR, and Comparison with In Situ Hybridization Ernst J. M. Speel, Frans C. S. Ramaekers, and Anton H. N. Hopman ...... 405 60 Cycling Primed In Situ Amplification John H. Bull and Lynn Paskins ...... 425 61 Direct and Indirect In Situ PCR Klaus Hermann Wiedorn and Torsten Goldmann ...... 433 62 Reverse Transcriptase In Situ PCR: New Methods in Cellular Interrogation Mark Gilchrist and A. Dean Befus ...... 445 63 Primed In Situ Nucleic Acid Labeling Combined with Immunocytochemistry to Simultaneously Localize DNA and Proteins in Cells and Chromosomes Ernst J. M. Speel, Frans C. S. Ramaekers, and Anton H. N. Hopman ...... 453 xii Contents
PART IX. CLONING AND MUTAGENESIS 64 Cloning and Mutagenesis: A Technical Overview Helen Pearson and David Stirling...... 467 65 Using T4 DNA Polymerase to Generate Clonable PCR Products Kai Wang ...... 469 66 A T-Linker Strategy for Modification and Directional Cloning of PCR Products Robert M. Horton, Raghavanpillai Raju, and Bianca M. Conti-Fine ...... 475 67 Cloning Gene Family Members Using PCR with Degenerate Oligonucleotide Primers Gregory M. Preston ...... 485 68 cDNA Libraries from a Low Amount of Cells Philippe Ravassard, Christine Icard-Liepkalns, Jacques Mallet, and Jean Baptiste Dumas Milne Edwards ...... 499 69 Creation of Chimeric Junctions, Deletions, and Insertions by PCR Genevieve Pont-Kingdon ...... 511 70 Recombination and Site-Directed Mutagenesis Using Recombination PCR Douglas H. Jones and Stanley C. Winistorfer ...... 517 71 Megaprimer PCR: Application in Mutagenesis and Gene Fusion Emily Burke and Sailen Barik ...... 525 Index ...... 533 Contributors
KENJI ABE • Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan MITSUTERU AKAHOSHI • Genetic Polymorphism and Function Assay Group, Genetic Polymorphism Institute, RIKEN Yokohama Institute, Yokohama, Japan YAQOUB ASHHAB • Unidad de Inmunología, Hospital Universitario Germans Trias i Pujol, and Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain MICHAELA AUBELE • Institute of Pathology, GSF-National Research Center for Environment and Health, Neuherberg, Germany SAILEN BARIK • Department of Biochemistry and Molecular Biology and Department of Microbiology and Immunology, University of South Alabama College of Medicine, Mobile, AL JOHN M. S. BARTLETT • Endocrine Cancer Group, Division of Cancer and Molecular Pathology, University Department of Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom PETER B. BECKER • Adolf-Butenandt-Institut, Ludwig Maximilians Universität, Munchen, Germany DEAN BEFUS • Glaxo-Heritage Asthma Research Laboratory, Pulmonary Research Group, Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada EVA BELLOSO • Unidad de Inmunología, Hospital Universitario Germans Trias i Pujol, and Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain WILLIAM H. BENJAMIN, JR. • Departments of Pathology and Microbiology, University of Alabama at Birmingham, Birmingham, AL EDSON BERTOLINI • Department of Plant Protection and Biotechnology, Instituto Valenciano de Investigaciones Agrarias, Valencia, Spain THOMAS C. G. BOSCH • Zoological Institute, University of Kiel, Kiel Germany DAVID BOYLE • Sidney Kimmel Cancer Center, San Diego, CA JENS BUKH • Hepatitis Viruses and Molecular Hepatitis Sections, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD JOHN H. BULL • CMC International Ltd, Macclesfield, Cheshire, UK EMILY BURKE • The Scripps Research Institute, La Jolla, CA MARIANO CAMBRA • Department of Plant Protection and Biotechnology, Instituto Valenciano de Investigaciones Agrarias, Valencia, Spain PETER CARROLL • Medlen & Carroll, LLP, Cambridge, MA STEPHEN CASE-GREEN • Department of Biochemistry, University of Oxford, Oxford, UK DAVID CASIMIR • Medlen & Carroll, LLP, Madison, WI xiii xiv Contributors
JINGWEN CHEN • Department of Technology Development, GlaxoSmithKline, Research Triangle Park, NC ALISON J. COFFEY • The Wellcome Trust Sanger Institute, Cambridge, UK BIANCA CONTI-FINE • Department of Biochemistry, University of Minnesota, St. Paul, MN FRIEDRICH W. CREMER • Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany RANIL S. DASSANAYAKE • Faculty of Medicine, Department of Biochemistry and Molecular Biology, University of Colombo, Sri Lanka ORLANDO DOMINGUEZ • Programa de Biotechnologia, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain JEAN BAPTISTE DUMAS MILNE EDWARDS • GENSET, Paris, France IAN DUNHAM • The Wellcome Trust Sanger Institute, Cambridge, UK JOHN J. DUNN • Biology Department, Brookhaven National Laboratory, Upton, NY JOANNE EDWARDS • Endocrine Cancer Group, Division of Cancer and Molecular Pathology, University Department of Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom RUPERT EGENSPERGER • Institute of Neuropathology, University of Münster, Münster, Germany MORTIMER M. ELKIND • Department of Radiological Health Sciences, Colorado State University, Fort Collins, CO SUZANNE U. EMERSON • Hepatitis Viruses and Molecular Hepatitis Sections, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD OLGA ESTEBAN • Department of Plant Protection and Biotechnology, Instituto Valenciano de Investigaciones Agrarias, Valencia, Spain MARK GILCHRIST • Glaxo-Heritage Asthma Research Laboratory, Pulmonary Research Group, Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada JAMES J. GOING • Department of Pathology, Glasgow Royal Infirmary, Glasgow, UK TORSTEN GOLDMANN • Clinical and Experimental Pathology, Research Center Borstel, Borstel, Germany MANUEL B. GRAEBER • Department of Neuropathology, Imperial College, London, UK HAIYING GRUNENWALD • Epicentre Technologies Corp., Madison, WI MEI HAN • Transplantation Immunology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX TAKUYA HIGASHIYAMA • Molecular Biology Program, Sidney Kimmel Cancer Center, San Diego, CA ANTON H. N. HOPMAN • Department of Molecular Cell Biology, Research Institute Growth & Development, University of Maastricht, The Netherlands ROBERT M. HORTON • Attotron Biosensor Corp., Carson City, NV DAVID L. HYNDMAN • Software Development, Automation Biology Drug Discovery Department, Ribapharm Inc., Costa Mesa, CA MARIE A. IANNONE • Department of Gene Expression and Protein Biochemistry, GlaxoSmithKline, Research Triangle Park, NC CHRISTINE ICARD-LIEPKALNS • GENSET, Paris, France Contributors xv
DOUGLAS H. JONES • Cedar Centre, Cedar Rapids, IA RON KERR • Department of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK KOSTYA KHALTURIN • Zoological Institute, University of Kiel, Kiel, Germany SIEGFRIED KÖSEL • Labor Becker, Olgemöller & Kollegen, Munich, Germany SERGEJ KUZNETSOV • Zoological Institute, University of Kiel, Kiel, Germany MAY-SUNG LI • Bio-Informatics Group Inc., NC JINGMEI LIU • Life Sciences Division, Los Alamos National Laboratory, Los Alamos, NM CHRISTOPH B. LÜCKING • Department of Neurology, University of Munich, Munich, Germany JACQUES MALLET • CNRS, Paris, France GEORGES-RAOUL MAZARS • Université Paul Sabatier, Tailaise, France MARCIA A. MCALEER • Department of Molecular Biology, Yamanouchi Research Institute, Oxford, UK MICHAEL MCCLELLAND • Molecular Biology Program, Sidney Kimmel Cancer Center, San Diego, CA SUSAN MCDONAGH • Department of Stomatology, University of California, San Francisco, CA MASATO MITSUHASHI • Hitachi Chemical Research Center, Irvine, CA MARION MOOSE • Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany HITOSHI NAKASHIMA • Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan KARIN A. OIEN • CRC Department of Medical Oncology, University of Glasgow, Glasgow, UK ANTONIO OLMOS • Department of Plant Protection and Biotechnology, Instituto Valenciano de Investigaciones Agrarias, Valencia, Spain LYNN PASKINS • a-1 biotech UK, Bedfordshire, UK HELEN PEARSON • Molecular Endocrinology Unit, Western General Hospital, Edinburgh, UK GENEVIEVE PONT-KINGDON • ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT STEFFEN PORWOLLIK • Molecular Biology Program, Sidney Kimmel Cancer Center, San Diego, CA GREGORY M. PRESTON • Genomic and Proteomic Sciences, Pfizer Inc., Groton, CT CLARE PRITCHARD • Harwell Microarray Facility, MRC Mammalian Genetics Unit, Harwell, Oxfordshire, UK RICARDO PUJOL-BORRELL • Unidad de Inmunología, Hospital Universitario Germans Trias i Pujol, and Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain ROBERT H. PURCELL • Hepatitis Viruses and Molecular Hepatitis Sections, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD JEAN-PIERRE QUIVY • Institut Curie, Section de Recherche UMR 218, Paris France RAGHAVANPILLAI RAJU • Department of Biochemistry, University of Minnesota, St. Paul, MN xvi Contributors
FRANS C. S. RAMAEKERS • Department of Molecular Cell Biology, Research Institute Growth & Development, University of Maastricht, The Netherlands PHILIPPE RAVASSARD • GENSET, Paris, France STEVEN RINGQUIST • Sidney Kimmel Cancer Center, San Diego, CA ROSA-ANA RISQUES • Sidney Kimmel Cancer Center, San Diego, CA KANOKPORN RITHIDECH • Department of Pathology, State University of New York at Stony Brook, Stony Brook, NY MARY ANN ROBINSON • Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD GAELLE RONDEAU • Sidney Kimmel Cancer Center, San Diego, CA LIDIA SABATER • Unidad de Inmunología, Hospital Universitario Germans Trias i Pujol, and Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain LAKSHMAN P. S AMARANAYAKE • Oral Bio-Sciences, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China WERA M. SCHMERER • Paleo DNA Laboratory, Department of Anthropology, Lakehead University, Thunder Bay, Ontario, Canada ZHIYUAN SHEN • Life Sciences Division, Los Alamos National Laboratory, Los Alamos, NM JAN SMIDA • Technische Universität München, Institute of Pathology, Munich, Germany KIM R. SMITH • Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL EDWIN SOUTHERN • Department of Biochemistry, University of Oxford, Oxford, UK ERNST J. M. SPEEL • Research Institute Growth & Development, Department of Molecular Cell Biology, University of Maastricht, The Netherlands DAVID STIRLING • Department of Hematology, Royal Infirmary of Edinburgh, Edinburgh, UK ANU SUOMALAINEN • Programme of Neurosciences and Department of Neurology, Biomedicum-Helsinki, Helsinki University, Helsinki, Finland ANN-CHRISTINE SYVÄNEN • Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden YOSUKE TANAKA • Department of Internal Medicine, Sawara Hospital, Meinohama Nishi-ku, Japan J. DAVID TAYLOR • Department of Technology Development, GlaxoSmithKline, Research Triangle Park, NC RAYMOND TELLIER • Division of Microbiology, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada CHARLES THEILLET • INSERM, Cancer Center of Montpellier, Montpellier, France KEN B. WAITES, Departments of Pathology and Microbiology, University of Alabama at Birmingham, Birmingham, AL KAI WANG • PhenoGenomics Corp., Bothell, WA XIN WANG • CELERA, an Applera Corporation Business, Rockville, MD YI-PENG WANG • Molecular Biology Program, Sidney Kimmel Cancer Center, San Diego, CA Contributors xvii
DAVID WALSH • Crop Science Department, Scottish Agricultural College, Edinburgh, UK MICHAEL P. W EINER • 454 Corp., Branford, CT ROBERT L. WELLS • Radiological Health Sciences Department, Colorado State University, Fort Collins, CO JOHN WELSH • Molecular Biology Program, Sidney Kimmel Cancer Center, San Diego, CA ANNE WHITE • DNASHEF Technologies, Royal Infirmary of Edinburgh, Edinburgh, UK KLAUS HERMANN WIEDORN • Institut für Pathologie, Katharinenhospital Stuttgart, Stuttgart, Germany STANLEY C. WINISTORFER • Department of Physiology, University of Iowa, Iowa City, IA FEI YE • IcAgen Inc., Durham, NC W. SCOTT YOUNG III • Laboratory of Cellular and Molecular Regulation, National Institute of Mental Health, National Institutes of Health, Bethesda, MD (ISTORY OF 0#2
,
).42/$5#4)/. 4/ 0#2 (ISTORY OF 0#2
! 3HORT (ISTORY OF THE 0OLYMERASE #HAIN 2EACTION
*OHN - 3 "ARTLETT AND $AVID 3TIRLING
7KHGHYHORSPHQWRIWKHSRO\PHUDVHFKDLQUHDFWLRQ 3&5 KDVRIWHQEHHQOLNHQHG WRWKHGHYHORSPHQWRIWKH,QWHUQHWDQGDOWKRXJKWKLVGRHVULVNRYHUVWDWLQJWKHLPSDFW RI3&5RXWVLGHWKHVFLHQWLÀFFRPPXQLW\WKHFRPSDULVRQZRUNVZHOORQDQXPEHU RIOHYHOV%RWKLQYHQWLRQVKDYHHPHUJHGLQWKHODVW\HDUVWRWKHSRLQWZKHUHLWLV GLIÀFXOWWRLPDJLQHOLIHZLWKRXWWKHP%RWKKDYHJURZQIDUEH\RQGWKHFRQÀ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ÀF V\QWKHVLVRIQHZ'1$FRSLHVXVLQJ'1$SRO\PHUDVHVZHUHDOUHDG\VWDQGDUGWRROVLQ WKHUHSHUWRLUHRIWKHPROHFXODUELRORJLVWVRIWKHWLPH7KHQRYHOW\LQ0XOOLV·VFRQFHSW ZDVXVLQJWKHMX[WDSRVLWLRQRIWZRROLJRQXFOHRWLGHVFRPSOHPHQWDU\WRRSSRVLWHVWUDQGV RIWKH'1$WRVSHFLÀFDOO\DPSOLI\WKHUHJLRQEHWZHHQWKHPDQGWRDFKLHYHWKLVLQD UHSHWLWLYHPDQQHUVRWKDWWKHSURGXFWRIRQHURXQGRISRO\PHUDVHDFWLYLW\ZDVDGGHG WRWKHSRRORIWHPSODWHIRUWKHQH[WURXQGKHQFHWKHFKDLQUHDFWLRQ,QKLV(ISTORY OF 0#2 3DXO5DELQRZTXRWHV0XOOLVDVVD\LQJ
&ROM -ETHODS IN -OLECULAR "IOLOGY 6OL 0#2 0ROTOCOLS 3ECOND %DITION %DITED BY * - 3 "ARTLETT AND $ 3TIRLING © (UMANA 0RESS )NC 4OTOWA .*
"ARTLETT AND 3TIRLING 7KHWKLQJWKDWZDVWKH´$KDµWKH´(XUHNDµWKLQJDERXW3&5ZDVQ·WMXVWSXWWLQJWKRVH >WKLQJV@WRJHWKHU«WKHUHPDUNDEOHSDUWLVWKDW\RXZLOOSXOORXWDOLWWOHSLHFHRI'1$IURP LWVFRQWH[WDQGWKDW·VZKDW\RXZLOOJHWDPSOLÀHG7KDWZDVWKHWKLQJWKDWVDLG´\RXFRXOG XVHWKLVWRLVRODWHDIUDJPHQWRI'1$IURPDFRPSOH[SLHFHRI'1$IURPLWVFRQWH[Wµ 7KDWZDVZKDW,WKLQNRIDVWKHJHQLXVWKLQJ«,QDVHQVH,SXWWRJHWKHUHOHPHQWVWKDW ZHUHDOUHDG\WKHUH«